ALS Limited (ALQ) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to ALS Limited H1FY26 results briefing. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you'll need to press star 1 and 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star one and one again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Malcolm Dean, CEO and Managing Director. Please go ahead. Thanks, Maggie, and good morning, and thank you all for taking the time to join today's briefing. It is great to be back with all of you to share ALS Fiscal Year 26 half-year results. It has been another strong period for ALS, a half that reflects our ability to deliver through changing markets while staying disciplined on growth, margin, and cash. As usual, I'm joined by our Chief Financial Officer, Stuart Haddon. We intend that this presentation will take for approximately 30 minutes and will follow with a Q&A session. Let me start by running through the highlights of the half year results. We are pleased to have delivered another set of strong results in line with our strategy plan. We produced revenue growth of 13.3% to 1.7 billion and pleasingly organic growth was recorded across all business streams. Underlying EBIT increased by 14.7% to 287.2 million and the EBIT margin strengthened by 20 basis points to 17.3%. Excluding acquisitions, the EBIT margin was 19.1%. Commodities performed strongly with positive market conditions supporting low meat-teens organic growth in both minerals and industrial materials. Life Sciences was solid with a...